These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 15615268)

  • 1. [Clozapine for the treatment of psychosis in 3 elderly patients with Parkinson's disease].
    Diraoui S; van Melick EJ; Jansen PA
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2365-8. PubMed ID: 15615268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine for the treatment of psychosis in Parkinson's disease: chart review of 49 patients.
    Wagner ML; Defilippi JL; Menza MA; Sage JI
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):276-80. PubMed ID: 8854298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clozapine and olanzapine in the treatment of the psychotic disorders in Parkinson's disease].
    Chacón J
    Rev Neurol; 2004 Oct 1-15; 39(7):655-60. PubMed ID: 15490354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis.
    Frieling H; Hillemacher T; Ziegenbein M; Neundörfer B; Bleich S
    Eur Neuropsychopharmacol; 2007 Feb; 17(3):165-71. PubMed ID: 17070675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of psychosis in Parkinson's disease: safety considerations.
    Fernandez HH; Trieschmann ME; Friedman JH
    Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple re-challenges for clozapine neutropenia in Parkinson's disease.
    Komaragiri A; Friedman JH
    Parkinsonism Relat Disord; 2016 Feb; 23():114-5. PubMed ID: 26717858
    [No Abstract]   [Full Text] [Related]  

  • 7. Clozapine and risperidone treatment of psychosis in Parkinson's disease.
    Ellis T; Cudkowicz ME; Sexton PM; Growdon JH
    J Neuropsychiatry Clin Neurosci; 2000; 12(3):364-9. PubMed ID: 10956570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.
    Broadstock M; Ballard C; Corbett A
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):779-86. PubMed ID: 25301532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis in Parkinson's disease: therapeutic options.
    Hasnain M
    Drugs Today (Barc); 2011 May; 47(5):353-67. PubMed ID: 22013566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotic drugs in the treatment of Parkinson's disease.
    Friedman JH
    J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
    Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: results of an open label pilot study.
    Friedman JH; Goldstein S; Jacques C
    Clin Neuropharmacol; 1998; 21(5):285-8. PubMed ID: 9789708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine in Parkinson's disease psychosis: 5-year follow-up review.
    Klein C; Gordon J; Pollak L; Rabey JM
    Clin Neuropharmacol; 2003; 26(1):8-11. PubMed ID: 12567158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine treatment of psychosis in Parkinson's disease: a report of five consecutive cases.
    Wolk SI; Douglas CJ
    J Clin Psychiatry; 1992 Oct; 53(10):373-6. PubMed ID: 1358876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of behavioural symptoms and dementia in Parkinson's disease.
    Hanagasi HA; Emre M
    Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
    Fernandez HH; Trieschmann ME; Okun MS
    Mov Disord; 2005 Jan; 20(1):104-5. PubMed ID: 15390047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia.
    Marsh L; Lyketsos C; Reich SG
    Psychosomatics; 2001; 42(6):477-81. PubMed ID: 11815682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pimavanserin: a new treatment for the Parkinson's disease psychosis].
    Duits JH; Ongering MS; Martens HJM; Schulte PFJ
    Tijdschr Psychiatr; 2017; 59(9):528-536. PubMed ID: 28880354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine as a treatment for psychosis in Parkinson's disease: a review.
    Musser WS; Akil M
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):1-9. PubMed ID: 8845691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.